Cencora Inc. (COR NYSE) stock market data APIs
$359.9933
3.75(1%)
as of February 10, 2026
Try our APIs with
free plan!
Cencora Inc. Financial Data Overview
Price chart is built with
Anychart
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Prev. Close
359.9933
Open
363.7451
High
366.4611
Low
356.1152
52 wk Range
236.4215-377.54
Market Cap
70 031 M
P/E Ratio
43.2692
Shares Outstanding
195 M
Revenue
325 778 M
EPS
2.87
Dividends (Yield)
0.0062
Beta
0.685
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cencora Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cencora Inc. data using free add-ons & libraries
Get Cencora Inc. Fundamental Data
Cencora Inc. Fundamental data includes:
- Net Revenue: 325 778 M
- EBITDA: 4 993 M
- Earnings Per Share: 8
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-04
- EPS/Forecast: 3.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cencora Inc. News
New
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056
CONSHOHOCKEN, Pa., February 10, 2026--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 3.950% Senior Notes due February 13, 2029...
Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors
NEW YORK CITY, NY / ACCESS Newswire / February 9, 2026 / Chief Executives for Corporate Purpose® (CECP) announced today that three distinguished executives will join the organization's Board of Direc...
Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2
Cardinal Health, Inc. (NYSE:CAH) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts.Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2 Morgan S...
Is It Too Late To Consider Cencora (COR) After A 46% One-Year Rally?
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. If you are wondering whether Cencora's current share price still offers value, you are not ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
